Sort   by:  
 Page size 
TranscriptomicsCell-to-cell gene expression variability followed by reinforcement progressively segregates lineages in the early mouse embryo
Mammalian embryonic development begins with the specification and segregation of the two extra-embryonic lineages, trophectoderm and primitive endoderm, from the pluripotent embryonic lineage, the epiblast. To establish a map of epiblast (EPI) versus primitive endoderm (PrE) lineage segregation whic...
ORGANISM(S): Mus musculus 
2013-11-26 | E-MTAB-1681 | biostudies-arrayexpress
TranscriptomicsIdentification of right heart-enriched genes in a murine model of chronic outflow tract obstruction
The right ventricle (RV) differs in several aspects from the left ventricle (LV) including its embryonic origin, physiological role and anatomical design. In contrast to LV hypertrophy, little is known about the molecular circuits, which are activated upon RV hypertrophy (RVH). We established a high...
ORGANISM(S): Mus musculus 
2011-07-07 | E-GEOD-30428 | biostudies-arrayexpress
UnknownTERT gene harbors multiple variants associated with pancreatic cancer susceptibility.
Not available
S-EPMC4548797 | biostudies-literature
TranscriptomicsTranscriptomics analysis of different porcine intestinal models (piglet jejunums, jejunum crypts, and organoids) and conventional cell line models upon infection with the transmissible gastroenteritis virus (TGEV)
The objective is to study the relevance of porcine intestinal models (incl. piglet jejunums, 2D and 3D organoids derived from piglet jejunums and swine testicular cells) to study intestinal functions and to decipher the host-virus interactions during viral porcine coronavirus infection. This dataset...
ORGANISM(S): Sus scrofa 
2025-10-10 | E-MTAB-15113 | biostudies-arrayexpress
GenomicsDerivation of novel human ground state naM-CM-/ve pluripotent stem cells.
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
ORGANISM(S): Homo sapiens 
2013-11-29 | E-GEOD-52824 | biostudies-arrayexpress
UnknownThe advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.
Not available
S-EPMC4802157 | biostudies-literature
UnknownAssessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Not available
S-EPMC3235950 | biostudies-literature
UnknownLetrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
Not available
S-EPMC2921823 | biostudies-literature
UnknownLong-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Not available
S-EPMC3596060 | biostudies-literature
Sort   by:  
 Page size